1,064 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
JNJ Johnson & Johnson $139.96 $375.48B N/A
Article Searches
5 Stocks to Prepare for a Global Economic Slowdown http://www.zacks.com/stock/news/376479/5-stocks-to-prepare-for-a-global-economic-slowdown?cid=CS-ZC-FT-376479 Apr 10, 2019 - In such an event, demand for products and services generated by utilities, consumer staples and medical companies remain invariant.
Glaxo's Dovato Gets FDA Nod for Treatment-Naive HIV Patients http://www.zacks.com/stock/news/372924/glaxos-dovato-gets-fda-nod-for-treatment-naive-hiv-patients?cid=CS-ZC-FT-372924 Apr 09, 2019 - Glaxo's (GSK) ViiV Healthcare gets FDA approval for a single-tablet two-drug regimen (2DR), Dovato for treatment naive HIV- 1 adults.
Aeglea (AGLE) Reports New Positive Data for Pegzilarginase http://www.zacks.com/stock/news/372396/aeglea-agle-reports-new-positive-data-for-pegzilarginase?cid=CS-ZC-FT-372396 Apr 08, 2019 - Aeglea (AGLE) reports new positive data for pegzilarginase in patients with Arginase 1 Deficiency.
Company News For Apr 8, 2019 http://www.zacks.com/stock/news/372304/company-news-for-apr-8-2019?cid=CS-ZC--372304 Apr 08, 2019 - Companies In The News Are: BA, ABMD, TGI, C, JNJ
Roche Extends Offer Period for Spark Therapeutics Acquisition http://www.zacks.com/stock/news/370066/roche-extends-offer-period-for-spark-therapeutics-acquisition?cid=CS-ZC-FT-370066 Apr 03, 2019 - Roche (RHHBY) withdraws its Premerger Notification and Report Form in connection with the pending acquisition of Spark Therapeutics.
Novartis Gets Approval for Psoriasis Drug Cosentyx in China http://www.zacks.com/stock/news/369420/novartis-gets-approval-for-psoriasis-drug-cosentyx-in-china?cid=CS-ZC-FT-369420 Apr 02, 2019 - Novartis' (NVS) psoriasis drug gets approval in China. The company also signs an agreement to expand its biologics therapy manufacturing capability.
Company News For Apr 2, 2019 http://www.zacks.com/stock/news/369195/company-news-for-apr-2-2019?cid=CS-ZC--369195 Apr 02, 2019 - Companies in the news are: JNJ, SCOR, VFF and TGTX
Spero Gets Fast Track Designation for SPR994, Shares Improve http://www.zacks.com/stock/news/368643/spero-gets-fast-track-designation-for-spr994-shares-improve?cid=CS-ZC-FT-368643 Apr 01, 2019 - Spero???s (SPRO) SPR994 receives Fast Track designation by the FDA for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis.
3 Big Pharma Stocks to Add to Your Portfolio This April http://www.zacks.com/stock/news/368171/3-big-pharma-stocks-to-add-to-your-portfolio-this-april?cid=CS-ZC-FT-368171 Apr 01, 2019 - The large-cap pharma industry is on a strong footing in 2019. Here are three stocks from the space that investors may consider betting on.
Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug Approvals http://www.zacks.com/stock/news/367176/pharma-stock-roundup-azn-inks-cancer-deal-abbv-nvs-others-get-drug-approvals?cid=CS-ZC-FT-367176 Mar 29, 2019 - AstraZeneca announces a $6.9 billion cancer deal with Daiichi Sankyo. AbbVie (ABBV), Novartis (NVS) & AstraZeneca's (AZN) drugs get regulatory approvals.

Pages: 12345678910...107

<<<Page 5>